Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) CEO Jitendra Mohan sold 96,089 shares of the firm’s stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $206.62, for a total value of $19,853,909.18. Following the completion of the sale, the chief executive officer directly owned 1,170,576 shares in the company, valued at $241,864,413.12. This trade represents a 7.59% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Astera Labs Stock Down 2.4%
Shares of ALAB opened at $211.60 on Friday. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm has a market capitalization of $36.98 billion, a price-to-earnings ratio of 95.07 and a beta of 3.85. The stock’s 50-day moving average price is $287.43 and its 200 day moving average price is $258.14.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.19 by $0.13. The business had revenue of $584.90 million for the quarter, compared to analyst estimates of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. Astera Labs’s quarterly revenue was up 153.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.49 EPS. Equities research analysts expect that Astera Labs, Inc. will post 2.99 EPS for the current year.
Top Astera Labs Stories
- Positive Sentiment: Astera’s expanded partnership with Hyve Solutions will integrate its Orion Compute Board, Fabric Tray and Link Board into Hyve’s Apex platform. The pre-validated components are intended to speed AI-rack deployment and offer enterprise and neocloud customers flexibility as accelerator needs grow. Article: Hyve Partnership Might Change the Case for Investing in Astera Labs
- Positive Sentiment: Recent coverage points to a strong earnings backdrop: Astera’s latest reported quarter beat estimates, with revenue up 153.6% year over year. A new price-prediction article says traders are leaning bullish, though it characterizes the rebound as fragile. Article: Earnings Beat Meets a Fragile Bounce
- Neutral Sentiment: Several executives, including the CEO, COO and general counsel, reported share sales from November 16. The filings say the transactions covered tax withholding on vested equity awards; executives retained substantial holdings, making the sales less clearly bearish than discretionary sales. Article: Astera Labs General Counsel Sells Stock
Institutional Trading of Astera Labs
Institutional investors have recently modified their holdings of the company. BlackRock Inc. acquired a new stake in Astera Labs in the 2nd quarter valued at about $6,609,581,000. Atreides Management LP raised its stake in Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Van ECK Associates Corp boosted its stake in shares of Astera Labs by 20.0% in the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock valued at $1,080,980,000 after buying an additional 373,545 shares during the period. Bank of America Corp DE bought a new stake in Astera Labs during the second quarter worth about $1,061,791,000. Finally, Amundi increased its stake in Astera Labs by 77.9% in the first quarter. Amundi now owns 1,880,830 shares of the company’s stock valued at $206,139,000 after acquiring an additional 823,477 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on ALAB shares. Needham & Company LLC cut their price objective on shares of Astera Labs from $425.00 to $300.00 and set a “buy” rating for the company in a research report on Wednesday, November 4th. Susquehanna lowered their price objective on shares of Astera Labs from $310.00 to $258.00 and set a “neutral” rating for the company in a research note on Wednesday, November 4th. TD Cowen reduced their price target on shares of Astera Labs from $300.00 to $225.00 and set a “hold” rating for the company in a research report on Wednesday, November 4th. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Finally, Weiss Ratings cut shares of Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a report on Friday, October 23rd. Twelve equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $325.89.
Astera Labs Company Profile
Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.
See Also
- Five stocks we like better than Astera Labs
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
